Lantern Pharma Company
Lantern Pharma is an oncology-focused, emerging, clinical stage pharma leveraging Artificial Intelligence, Genomics, and Machine Learning to transform the cost, pace, and timeline of drug discovery and development.
Founded Date:
2013-01-01
Total Funding:
50085302
Employee Number:
11-50
Funding Status:
IPO
Technology:
['BioTech & HealthTech']
Last Funding Type:
Series D
Investors Number:
4
Last Funding Date:
2021-01-14
Industry:
Biotechnology company
Headquarters:
Dallas, Texas, United States
Estimated Revenue:
$0.068B